Longitudinal Knowledge Assessment
Charlene Prather, MD, PhD, Chair
Dr. Prather is a gastroenterologist and Professor of Internal Medicine in the Division of Gastroenterology and Hepatology at Saint Louis University School of Medicine. She is also Director of the school’s GI Fellowship Training Program. She is American Board of Internal Medicine (ABIM) certified in Gastroenterology and Internal Medicine.
Dr. Prather specializes in digestive disorders, including irritable bowel syndrome, constipation, diarrhea, bowel incontinence, pelvic floor disorders and esophageal disorders such as achalasia, GERD and Barrett esophagus. She uses the latest treatment techniques, such as capsules that send data signals from inside the digestive tract to a recording device worn outside the body, capsules that record video as they travel through the digestive tract, and non-surgical incontinence treatments such as injections and pelvic floor retraining.
Dr. Prather is a medical journal reviewer and a sought-after speaker on GI issues. She is active in many professional organizations, including the American Medical Association, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. She serves as a member of the American Board of Internal Medicine Gastroenterology Board Exam Committee.
She completed her medical degree and residency at the University of Missouri at Kansas City and her fellowship at Mayo Clinic.
As of June 2022, Dr. Prather reported no ongoing external relationships.
Brian Kim, MD
Dr. Kim is an Associate Professor of Clinical Medicine at the Keck School of Medicine of the University of Southern California (USC). He is a transplant hepatologist specializing in the treatment of patients with acute and chronic liver disease, cirrhosis and hepatocellular carcinoma. He is also the Program Director for the Accreditation Council for Graduate Medical Education-approved Gastroenterology Fellowship at USC and serves as the chair of the USC Keck School of Medicine Gastrointestinal/Liver Course.
Dr. Kim is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. He is an active member of the American Association for the Study of Liver Diseases (AASLD) where he serves as a member of the AASLD Maintenance of Certification Committee. He is also an active member of the American College of Gastroenterology and the American Gastroenterological Association.
Dr. Kim's clinical research interests include liver transplantation, living donor liver transplantation, cardiac diseases in liver patients and complications of portal hypertension. He has authored numerous chapters and articles in peer-reviewed journals on various topics in liver disease and liver transplantation.
Dr. Kim graduated with a Bachelor of Science in Molecular, Cellular and Developmental Biology from Yale University. He received his medical degree from Columbia University Roy and Diana Vagelos College of Physicians and Surgeons. He completed his internship and residency training in internal medicine at NewYork-Presbyterian/Columbia University Irving Medical Center. He completed a gastroenterology fellowship at the Johns Hopkins University School of Medicine and a transplant hepatology fellowship at the Icahn School of Medicine at Mount Sinai.
As of July 2022, Dr. Kim reported no external relationships.
Paul Martin, MD, FAAASLD
Dr. Martin is Professor of Medicine, Mandell Chair in Gastroenterology and Chief of the Division of Digestive and Liver Diseases at the University of Miami Miller School of Medicine in Florida. He is Editor-in Chief of Liver Transplantation and Editor of Handbook of Liver Disease. He was previously a Councilor of the American Society of Transplant.
He is a native of Dublin, Ireland, where he graduated from medical school at University College, Dublin. His training in internal medicine and gastroenterology was initially in Dublin and subsequently in Canada. He trained in hepatology as a medical staff fellow in the Liver Unit, National Institute of Health in Bethesda, Maryland.
As of May 2022, Dr. Martin reported the following external relationships.
Funding for clinical trial expenses, salary support and staff, paid to the University of Miami, from the following companies:
- AbbVie, providing funding for clinical trial expenses and staff.
- Durect, providing funding for clinical trial expenses, salary support, and staff.
Service on data and safety monitoring boards for the following companies, with honoraria:
- Merck
Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:
- AbbVie
- Gilead
Joseph Yarze, MD
Dr. Yarze is a board certified internist and gastroenterologist. Since 1994, he has been in private practice at the Gastroenterology Associates of Northern New York in Glens Falls, New York.
In 1991, Dr. Yarze worked as a gastroenterology staff consultant at The Guthrie Clinic in Sayre, Pennsylvania. While there, he received the Dean’s Award for Excellence in Clinical Teaching from the Hahnemann Medical School. Dr. Yarze has previously served as the Medical Director of the Glens Falls Hospital GI Center and as the Quality Improvement Officer for Northern GI Endoscopy, an office-based ambulatory endoscopy unit.
Dr. Yarze serves on the American Board of Internal Medicine Gastroenterology Board Exam Committee. He presently serves on the Editorial Review Board for Gastrointestinal Endoscopy. Dr. Yarze is a volunteer teacher at Albany Medical College, where he is a Clinical Associate Professor of Medicine. He previously served on the American Society for Gastrointestinal Endoscopy (ASGE) Standards of Practice, Healthcare and Public Policy and Budget and Financial Planning Committees. Dr. Yarze implemented and staffs a “free for service” gastroenterology clinic on his weekends off, which serves the uninsured in rural northeastern New York. He has contributed more than 185 articles/book chapters/letters and abstracts in peer-reviewed journals and books. Dr. Yarze is a Fellow of the American College of Physicians, the American College of Gastroenterology, the American Society for Gastrointestinal Endoscopy, the American Gastroenterological Association and the American Association for the Study of Liver Diseases.
Dr. Yarze matriculated into medical school prior to completing undergraduate studies in chemistry at Rutgers University and holds a medical degree from Rutgers Medical School. He completed his internship, residency and fellowship in gastroenterology at the Thomas Jefferson University Hospital, in Philadelphia, Pennsylvania.
As of August 2022, Dr. Yarze reported no external relationships.
Traditional, 10-Year MOC Exam
Amar R. Deshpande, MD, Chair
Dr. Deshpande, a board certified internist and gastroenterologist, is Professor of Medicine in the Division of Digestive Health and Liver Diseases and the Associate Dean for Medical Education and Administration at the University of Miami (UM) Miller School of Medicine. He is also co-Director of the Advanced Inflammatory Bowel Disease (IBD) Fellowship and Vice Chair for Education in the Department of Medicine. Dr. Deshpande sees patients and does research at the University of Miami Crohn's and Colitis Center. He was previously the Program Director of the Gastroenterology Fellowship, co-Director of the Internal Medicine clerkship for third-year medical students and director of the pathophysiology modules for second-year medical students, roles for which he has won numerous teaching awards. He is also the faculty advisor of the student-run Department of Community Service at UM, a group that has won national awards for its commitment to caring for thousands of the underserved in South Florida through health fairs, free clinics and other events.
Dr. Deshpande served as a member of the American Board of Internal Medicine Gastroenterology Traditional, 10-Year MOC Exam Approval Committee until 2023, when he was elected chair by the Gastroenterology Board. He has authored many articles, book chapters and reviews in prestigious gastroenterology and internal medicine journals, and conducted presentations at national and international meetings. Dr. Deshpande is a reviewer for multiple gastroenterology journals and sits on IBD-related advisory boards.
Dr. Deshpande completed his medical degree at the University of Miami School of Medicine and his internal medicine residency and gastroenterology fellowship at the University of Miami and Jackson Memorial Hospital.
As of July 2022, Dr. Deshpande reported the following external relationships:
Service on a research-related expert panel or advisory board, receiving compensation from the following company as listed:
- GI Health Foundation, Inflammatory Bowel Disease Advisory Board, receiving reimbursement for travel expenses and honoraria.
Dr. Deshpande serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The Gastrointestinal Health Foundation, for an inflammatory bowel disease advisory board, receiving reimbursement for travel expenses and honoraria.
Lin Chang, MD
Dr. Chang is a Professor of Medicine and gastroenterologist in the Division of Digestive Diseases, Department of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She serves as the co-Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience at the David Geffen School of Medicine at UCLA. She is also Program Director of the UCLA Gastroenterology Fellowship Program. She is board certified in Internal Medicine and Gastroenterology.
Dr. Chang's clinical expertise is in functional gastrointestinal disorders, which include irritable bowel syndrome (IBS), chronic constipation and functional dyspepsia. She is a National Institutes of Health (NIH)-funded investigator studying brain-gut interactions underlying IBS. Specifically, her research is focused on the pathophysiology of IBS related to stress, early life adversity, sex differences and genetic and epigenetic factors, as well as gut microbiome and the treatment of IBS.
Dr. Chang is a member of the ABIM Gastroenterology Board Exam Committee, the Rome Foundation Board of Directors, the Rome IV Editorial Board and the Functional Bowel Disorders Committee. She is a fellow of the American Gastroenterological Association and American College of Gastroenterology, and a member of the Society for Neuroscience. Currently, she is a member of the FDA Gastrointestinal Drugs Advisory Committee and the NIH Clinical, Integrative, Molecular Gastroenterology Study Section. She previously served as President of the American Neurogastroenterology and Motility Society. She is Associate Editor of Clinical Gastroenterology and Hepatology. Dr. Chang is the recipient of the Janssen Award in Gastroenterology for Basic or Clinical Research and the AGA Distinguished Clinician Award. She has authored more than 100 original research articles, 50 review articles, and 20 book chapters on her specialty interests.
Dr. Chang earned a medical degree from UCLA School of Medicine. She completed internal medicine residency and a medicine/gastroenterology fellowship at Harbor-UCLA Medical Center.
As of August 2022, Dr. Chang reported the following external relationships:
Funding for clinical trial expenses and staff, paid to the University of California, Los Angeles, from the following companies:
- AnX Robotica, receiving salary support and funding for clinical trials expenses and staff
- Arena, receiving funding for clinical trials expenses and staff
- Innovative Health Solutions, receiving funding for clinical trials expenses and staff
Service on a research-related advisory board for the following companies, receiving honoraria:
- Arena Pharmaceuticals
- Immunic
- Ironwood Pharma
- Mauna Kea Technologies
- Trellus
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- The American College of Gastroenterology, regional lectures
- Ironwood Pharma, for an irritable bowel syndrome lecture
- Paradigm, for an irritable bowel syndrome and constipation lecture
- The Rome Foundation, for a nurse practitioner/physician assistant program
Teaching in satellite symposia funded by the following company, with honoraria:
- AbbVie, for irritable bowel syndrome awareness lectures
Dr. Chang serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The American Gastroenterological Association, Clinical Gastroenterology and Hepatology, Associate Editor, receiving honoraria
- The Rome Foundation, Board Member, receiving reimbursement for travel expenses
Kerry Dunbar, MD
Dr. Kerry Dunbar is an Associate Professor of Medicine at the University of Texas (UT) Southwestern Medical School and the Gastroenterology Section Chief at the VA North Texas Healthcare System. She is also an Associate Program Director for the UT Southwestern Internal Medicine residency training program. She is board certified in Gastroenterology.
Dr. Dunbar's clinical and research interests include esophageal diseases, such as gastroesophageal reflux disease, Barrett's esophagus, and esophageal motility disorders. She also has a clinical and research interest in colorectal cancer screening and colonoscopy outcomes. She is a Fellow of the American Gastroenterological Association and of the American Society of Gastrointestinal Endoscopy. She serves as a member of the ABIM Internal Medicine Gastroenterology Board Exam Committee.
Dr. Dunbar graduated from UT Southwestern Medical School and completed internal medicine residency and gastroenterology and hepatology fellowship at Johns Hopkins. During fellowship, she completed an Assistant Chief of Service year and pursued research training through the Johns Hopkins Bloomberg School of Public Health Graduate Training Program in Clinical Investigation, for which she received a PhD in 2012.
As of August 2022, Dr. Dunbar reported the following external relationships:
Dr. Dunbar serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American Gastroenterological Association, Councilor for the esophagogastric duodenoscopy section and imaging/endoscopy/advanced technology sections; abstract reviewer for the Barrett's esophagus/gastroesophageal reflux disease pathogenesis section, without compensation
- Johns Hopkins University Heartburn Center, Research Advisory Board, Member, without compensation
- The American Foregut Society, Foregut, Senior Associate Editor, Board of Directors, receiving reimbursement for travel expenses
Grant funding for expenses and staff, paid to VA North Texas Health Care System – Dallas VA Medical Center, from the following companies:
- Veterans Health Administration, VA Merit Review Grant for Barrett's esophagus research, receiving funding for staff
Divyanshoo Kohli, MD
Dr. Kohli is an interventional endoscopist working at Providence Digestive Health Institute in Spokane, Washington. Prior to his current position, he served as the Director of Endoscopy at the Kansas City VA Medical Center in Missouri and as adjunct faculty for the Gastroenterology and Hepatology Fellowship Program at Kansas University School of Medicine.
Dr. Kohli has served with the American Board of Internal Medicine (ABIM) in multiple roles including as a member of the standard-setting panel, a member and pod leader of the Item-Writing Task Force and member of the Gastroenterology Board since 2022. He joined the Gastroenterology Traditional, 10-Year MOC Exam Approval Committee in 2023. He has received a commendation from ABIM for his extraordinary performance and exemplary work. Dr. Kohli also serves on the Standards of Practice Committee at the American Society for Gastrointestinal Endoscopy, where he is involved in developing guidelines and best practices for clinicians. He has been recognized for his outstanding public service and professionalism by the Veterans Health Administration and is a recipient of the Saul Zuckerman Humanitarianism in Medicine Award for outstanding scholarship and compassion. He has authored more than 60 research papers and has received multiple awards for his leading-edge clinical research.
Dr. Kohli received his medical degree from Government Medical College and Hospital, Chandigarh in India, and completed his internship and residency in internal medicine at Georgetown University Medical Center in Washington, D.C. He completed his fellowship in gastroenterology, hepatology and nutrition at Virginia Commonwealth University, where he also served as Chief Fellow. He also completed an advanced endoscopy fellowship at the Mayo Clinic in Phoenix, Arizona.
As of July 2022, Dr. Kohli reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Kansas City Veterans Affairs Medical Center, from the following company:
- Olympus
Dr. Kohli serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The American Society for Gastrointestinal Endoscopy, Standards Practice Committee, Member, without compensation
David R. Lichtenstein, MD
Dr. Lichtenstein is the Director of Gastrointestinal Endoscopy at Boston Medical Center and Associate Professor of Medicine at Boston University School of Medicine. He is board certified in both Internal Medicine and Gastroenterology.
Dr. Lichtenstein is a recognized educator in endoscopic approaches for diagnosing and managing gastrointestinal hemorrhage, pancreaticobiliary tract disorders, and gastrointestinal malignancies. He supervises Gastroenterology Fellowship training in advanced endoscopic procedures and is responsible for evaluating and implementing new endoscopic technologies at Boston Medical Center.
Dr. Lichtenstein is member of the American Board of Internal Medicine Gastroenterology Board Exam Committee. He is an active member and current fellow of the American Society for Gastrointestinal Endoscopy (ASGE), American College of Gastroenterology and American Gastroenterological Association. He has been recognized in The Best Doctors in America, Boston Magazine's “Best Doctors of Boston”, as well as Castle Connolly's Guide to America's Top Doctors. He is the former Chair of the Endoscopic Retrograde Cholangiopancreatography Section of the Annual Scientific Program Committee for Digestive Disease Week, and Chair of the Assessment and Certification Task Force that introduced a series of Skills Training Assessment Reinforcement educational programs for the ASGE. He has also served on the ASGE Research, Standards of Practice, International, Web Education, Technology, and Gastrointestinal Endoscopy Self-Assessment Program Committees. In addition, he was the past President of the New England Endoscopy Society.
Dr. Lichtenstein received his medical degree from the University of Pennsylvania School of Medicine. He completed residency training in internal medicine at Duke University Medical Center and received fellowship training in gastroenterology at Beth Israel Hospital in Boston. He later served as Chief Medical Resident at Duke University Medical Center and subsequently received advanced interventional endoscopy training at Duke University Medical Center and Brigham and Women's Hospital.
As of May 2023, Dr. Lichtenstein reported the following external relationships:
Preclinical research, with funding for salary support, from the following companies:
- CDx Diagnostics, for a multicenter study to evaluate WATS for diagnosis of cholangiocarcinoma
- Olympus, for endoscopy device development lab work
Funding for clinical trial expenses and staff, paid to Boston University, from the following company:
- Iterative Scopes, serving as a principal investigator of a randomized, controlled trial of artificial intelligence in colonoscopy
Attendance at investigators’ meetings, without compensation from the following company:
- Iterative Scopes
Service on data and safety monitoring boards for the following companies, with honoraria:
- Boston Scientific, for service on a Clinical Events Committee
- Pallette Life Sciences, for service on a Clinical Events Committee
- SafeHeal, for an endoluminal bypass sheath study
Service on a research-related expert panel or advisory board for the following company, with compensation for travel expenses and honoraria:
- Iterative Scopes, for serving on an advisory board and as a research principal investigator
Consulting on the design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:
- Ambu Inc., for consulting for single-use duodenoscope development
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- Olympus, for a fellowship endoscopy course with hands-on training
Dr. Lichenstein serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The American Society for Gastrointestinal Endoscopy, Technology Committee, Chair, receiving reimbursement for travel expenses
Nancy S. Reau, MD
Dr. Reau, board certified in Internal Medicine, Gastroenterology and Transplant Hepatology, is currently Associate Director of Solid Organ Transplantation and Section Chief of Hepatology at Rush University Medical Center.
She previously served as Assistant Professor of Medicine at Rush University in Chicago from 2002 to 2005. She became an Associate Professor of Medicine in 2010, Medical Director of Hepatology Clinical and Translational Research in 2015, and then joined Rush University Medical Center in 2015.
Dr. Reau's research interest is in viral hepatitis, both in drug development as well as utilization. She is currently a member of the American Board of Internal Medicine Gastroenterology Board, the American Association for the Study of Liver Diseases (AASLD) steering committee for the hepatitis C special interest group and a member of the AASLD/IDSA Practice Guidelines for hepatitis C and served as the chair of the AASLD public policy committee. She is a member of the American College of Gastroenterology women's training committee. She has been a member of the national board of directors of the American Liver Foundation (ALF) and served as the president of the Illinois chapter. She is currently co-chair of the National ALF Medical Advisory Committee and serves on multiple advisory boards including Medscape and Medivo.
Dr. Reau received her undergraduate degree at Oberlin College in Oberlin Ohio and medical degree cum laude, from The Ohio State University in Columbus, Ohio. She completed a medicine residency and a gastroenterology fellowship at The Ohio State University. She went to the Johns Hopkins Medical Center in Baltimore, Maryland, where she did her advanced transplant hepatology fellowship in 2001.
As of August 2022, Dr. Reau reported the following external relationships:
Service on data and safety monitoring boards for the following company, with honoraria:
- Arbutus
Service on a research-related expert panel or advisory board for the following companies, with compensation as listed:
- AbbVie, serving on a national advisory board for clinical development in hepatitis C, receiving travel reimbursement and honoraria
- Antios, serving on an advisory board, receiving travel reimbursement and honoraria
- Gilead, serving on a national advisory board for clinical development in hepatitis C, receiving travel reimbursement and honoraria
- Intercept, serving on an advisory board, receiving travel reimbursement and honoraria
- Salix, serving on an advisory board, receiving travel reimbursement and honoraria
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- The Chronic Liver Disease Foundation, support from educational grants from multiple pharmaceutical companies for developing educational content for continuing medical education on hepatitis C, receiving honoraria
- Clinical Care Options, for developing educational content for continuing medical education on hepatitis C and providing updates to the American Association for the Study of Liver Disease, receiving honoraria
Dr. Reau serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American Association for the Study of Liver Diseases, Clinical Liver Disease, Editor, receiving honoraria.
- The American College of Gastroenterology, Continuing Medical Education courses, receiving honoraria and reimbursement for travel expenses